Prostaglandins and myogenic control of tension in lower esophageal sphincter in vitro

E. E. Daniel, J. Crankshaw, S. Sarna

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Active tension is produced by the lower esophageal sphincter (LES) of North American opossum in vitro by a myogenic mechanism. Strips of LES, but not those from the esophageal body, contracted to prostaglandin (PG)F, stable expoxymethano derivatives of PGH2 and to thromboxane B2. Stable endoperoxides were more than 500 times more potent than PGF. PGI2 and 6-keto PGF were weak relaxants of LES strips. LES strips transformed arachidonic acid into contractile substances. This transformation was prevented by agents which interfere with PG synthesis by inhibiting cyclo-oxygenase [indomethacin (IDM), 5,8,11,14-eicosatetraynoic acid (ETA) or thromboxane synthetase [imidazole]. Tranylcypromine 500 μg/ml also inhibited contractions to arachidonic acid. These agents also reduced muscle tone, so that endogenous PG formation may contribute to active tension in the LES. ETA and IDM increased tone before inhibiting it, and this effect was prevented by prior treatment with ETA or imidazole. There may also be an endogenous PG which inhibits LES tone. The possibility that this may be PGI2 is discussed.

Original languageEnglish (US)
Pages (from-to)629-639
Number of pages11
JournalProstaglandins
Volume17
Issue number4
DOIs
StatePublished - 1979
Externally publishedYes

Fingerprint

Lower Esophageal Sphincter
Prostaglandins
Dinoprost
Epoprostenol
Arachidonic Acid
Indomethacin
5,8,11,14-Eicosatetraynoic Acid
Thromboxane-A Synthase
Tranylcypromine
Prostaglandin H2
Thromboxane B2
Acids
Prostaglandin-Endoperoxide Synthases
Muscle
Didelphis
Derivatives
In Vitro Techniques
Muscles
imidazole

Keywords

  • Endoperoxides
  • Esophageal Body
  • Lower Esophageal Sphincter
  • Prostaglandin Receptors

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology

Cite this

Prostaglandins and myogenic control of tension in lower esophageal sphincter in vitro. / Daniel, E. E.; Crankshaw, J.; Sarna, S.

In: Prostaglandins, Vol. 17, No. 4, 1979, p. 629-639.

Research output: Contribution to journalArticle

Daniel, E. E. ; Crankshaw, J. ; Sarna, S. / Prostaglandins and myogenic control of tension in lower esophageal sphincter in vitro. In: Prostaglandins. 1979 ; Vol. 17, No. 4. pp. 629-639.
@article{977b9b8a1f1442bf8e57b9b6032c265a,
title = "Prostaglandins and myogenic control of tension in lower esophageal sphincter in vitro",
abstract = "Active tension is produced by the lower esophageal sphincter (LES) of North American opossum in vitro by a myogenic mechanism. Strips of LES, but not those from the esophageal body, contracted to prostaglandin (PG)F2α, stable expoxymethano derivatives of PGH2 and to thromboxane B2. Stable endoperoxides were more than 500 times more potent than PGF2α. PGI2 and 6-keto PGF1α were weak relaxants of LES strips. LES strips transformed arachidonic acid into contractile substances. This transformation was prevented by agents which interfere with PG synthesis by inhibiting cyclo-oxygenase [indomethacin (IDM), 5,8,11,14-eicosatetraynoic acid (ETA) or thromboxane synthetase [imidazole]. Tranylcypromine 500 μg/ml also inhibited contractions to arachidonic acid. These agents also reduced muscle tone, so that endogenous PG formation may contribute to active tension in the LES. ETA and IDM increased tone before inhibiting it, and this effect was prevented by prior treatment with ETA or imidazole. There may also be an endogenous PG which inhibits LES tone. The possibility that this may be PGI2 is discussed.",
keywords = "Endoperoxides, Esophageal Body, Lower Esophageal Sphincter, Prostaglandin Receptors",
author = "Daniel, {E. E.} and J. Crankshaw and S. Sarna",
year = "1979",
doi = "10.1016/0090-6980(79)90014-5",
language = "English (US)",
volume = "17",
pages = "629--639",
journal = "Prostaglandins and Other Lipid Mediators",
issn = "1098-8823",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Prostaglandins and myogenic control of tension in lower esophageal sphincter in vitro

AU - Daniel, E. E.

AU - Crankshaw, J.

AU - Sarna, S.

PY - 1979

Y1 - 1979

N2 - Active tension is produced by the lower esophageal sphincter (LES) of North American opossum in vitro by a myogenic mechanism. Strips of LES, but not those from the esophageal body, contracted to prostaglandin (PG)F2α, stable expoxymethano derivatives of PGH2 and to thromboxane B2. Stable endoperoxides were more than 500 times more potent than PGF2α. PGI2 and 6-keto PGF1α were weak relaxants of LES strips. LES strips transformed arachidonic acid into contractile substances. This transformation was prevented by agents which interfere with PG synthesis by inhibiting cyclo-oxygenase [indomethacin (IDM), 5,8,11,14-eicosatetraynoic acid (ETA) or thromboxane synthetase [imidazole]. Tranylcypromine 500 μg/ml also inhibited contractions to arachidonic acid. These agents also reduced muscle tone, so that endogenous PG formation may contribute to active tension in the LES. ETA and IDM increased tone before inhibiting it, and this effect was prevented by prior treatment with ETA or imidazole. There may also be an endogenous PG which inhibits LES tone. The possibility that this may be PGI2 is discussed.

AB - Active tension is produced by the lower esophageal sphincter (LES) of North American opossum in vitro by a myogenic mechanism. Strips of LES, but not those from the esophageal body, contracted to prostaglandin (PG)F2α, stable expoxymethano derivatives of PGH2 and to thromboxane B2. Stable endoperoxides were more than 500 times more potent than PGF2α. PGI2 and 6-keto PGF1α were weak relaxants of LES strips. LES strips transformed arachidonic acid into contractile substances. This transformation was prevented by agents which interfere with PG synthesis by inhibiting cyclo-oxygenase [indomethacin (IDM), 5,8,11,14-eicosatetraynoic acid (ETA) or thromboxane synthetase [imidazole]. Tranylcypromine 500 μg/ml also inhibited contractions to arachidonic acid. These agents also reduced muscle tone, so that endogenous PG formation may contribute to active tension in the LES. ETA and IDM increased tone before inhibiting it, and this effect was prevented by prior treatment with ETA or imidazole. There may also be an endogenous PG which inhibits LES tone. The possibility that this may be PGI2 is discussed.

KW - Endoperoxides

KW - Esophageal Body

KW - Lower Esophageal Sphincter

KW - Prostaglandin Receptors

UR - http://www.scopus.com/inward/record.url?scp=0018354766&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018354766&partnerID=8YFLogxK

U2 - 10.1016/0090-6980(79)90014-5

DO - 10.1016/0090-6980(79)90014-5

M3 - Article

C2 - 379920

AN - SCOPUS:0018354766

VL - 17

SP - 629

EP - 639

JO - Prostaglandins and Other Lipid Mediators

JF - Prostaglandins and Other Lipid Mediators

SN - 1098-8823

IS - 4

ER -